Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Down 4.4% – What’s Next?

Posted by Eileen French on Mar 27th, 2025

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report)’s stock price were down 4.4% during trading on Thursday . The company traded as low as $17.38 and last traded at $17.50. Approximately 11,323 shares were traded during trading, a decline of 64% from the average daily volume of 31,666 shares. The stock had previously closed at $18.30.

Analyst Ratings Changes

A number of equities analysts have weighed in on TLX shares. William Blair reaffirmed an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th. UBS Group boosted their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, January 27th.

Check Out Our Latest Stock Analysis on Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The business’s fifty day moving average price is $17.88.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.